MiRNA-21 promotes fibrosis in orbital fibroblasts from thyroid-associated ophthalmopathy

被引:2
|
作者
Tong Bo-ding
Xiao Man-Yi
Zeng Jie-Xi
Xiong Wei
机构
[1] Dept Ophthalmol, Changsha, Hunan, Peoples R China
[2] Eye Res Ctr, Changsha, Hunan, Peoples R China
来源
MOLECULAR VISION | 2015年 / 21卷
关键词
COLLAGEN EXPRESSION; MICRORNA-21; PROLIFERATION; PDCD4; PIRFENIDONE; ACTIVATION; MECHANISMS; CELLS; BETA;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: This study aimed to determine the role of miR-21 in orbital fibroblasts obtained from donors with thyroid-associated ophthalmopathy (TAO) and to elucidate the regulation of fibrosis by miR-21 in the pathological process of TAO. Methods: The expression of miR-21 was investigated in orbital tissues from 26 donors with TAO and 10 donors without TAO. Human orbital fibroblasts were cultivated from TAO donors, and the role of miR-21 in orbital fibroblast proliferation, apoptosis, and differentiation was analyzed. Moreover, the effect of transforming growth factor-beta1 (TGF-beta 1) on miR-21 expression was also analyzed. In addition, the regulation of miR-21 in TGF-beta 1-induced collagen production was determined. Results: The expression of miR-21 in orbital fibroblasts from TAO was higher than in donors without TAO. Additional experiments demonstrated that miR-21 enhanced proliferation, decreased apoptosis, and promoted differentiation in TAO orbital fibroblasts. Moreover, this study also showed that TGF-beta 1 induced miR-21 expression in a time-and dose-dependent manner and miR-21 promoted collagen I mRNA expression and total collagen production induced by TGF-beta 1. Additionally, miR-21 activated the TGF-beta 1/Smad signaling pathway by enhancing Smad3 phosphorylation. Conclusions: The present study shows that miR-21 regulates cell proliferation, apoptosis, and differentiation in orbital fibroblasts from TAO, and acts as a mediator in TGF-beta 1-induced collagen production. These data predict a close association between miR-21 and orbital muscle fibrosis, and provide a novel therapeutic target for TAO.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 50 条
  • [21] Progress in thyroid-associated ophthalmopathy
    Hiromatsu, Y
    Wall, JR
    THYROID, 2002, 12 (03) : 185 - 185
  • [22] Plasma exosomes from patients with active thyroid-associated orbitopathy induce inflammation and fibrosis in orbital fibroblasts
    Wei, Li
    Huang, Qinying
    Tu, Yunhai
    Song, Shihan
    Zhang, Xiaobo
    Yu, Bo
    Liu, Yufen
    Li, Ziwei
    Huang, Qing
    Chen, Lili
    Liu, Bo
    Xu, Shenglan
    Li, Tong
    Liu, Xiyuan
    Hu, Xiaozhou
    Liu, Weijie
    Chi, Zai-Long
    Wu, Wencan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [23] Rituximab for thyroid-associated ophthalmopathy
    Minakaran, Neda
    Ezra, Daniel G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (05):
  • [24] PATHOGENESIS OF THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 1993, 4 (08): : 270 - 275
  • [25] THE PATHOGENESIS OF THYROID-ASSOCIATED OPHTHALMOPATHY
    PERROS, P
    KENDALLTAYLOR, P
    JOURNAL OF ENDOCRINOLOGY, 1989, 122 (03) : 619 - 624
  • [26] Progress in thyroid-associated ophthalmopathy
    Wall, J
    Kennerdell, JS
    AUTOIMMUNITY, 1995, 22 (03) : 191 - 195
  • [27] GLYCOSAMINOGLYCANS IN THYROID-ASSOCIATED OPHTHALMOPATHY
    KAHALY, G
    STOVER, C
    OTTO, E
    BEYER, J
    SCHULER, M
    AUTOIMMUNITY, 1992, 13 (01) : 81 - 88
  • [28] Rituximab for thyroid-associated ophthalmopathy
    Kang, Swan
    Azzam, Shirin Hamed
    Minakaran, Neda
    Ezra, Daniel G.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2022, (06):
  • [29] Cytokines in Thyroid-Associated Ophthalmopathy
    Zhang, Pengbo
    Zhu, Huang
    JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [30] Octreoscan in thyroid-associated ophthalmopathy
    Krassas, GE
    THYROID, 2002, 12 (03) : 229 - 231